By targeting the root cause of pain, stem cell therapy can alleviate discomfort and reduce inflammation without relying on medications.

Stem cells have the unique ability to differentiate into various cell types, aiding in the regeneration of muscles, bones, and other tissues.

Stem cells have shown promise in treating a range of chronic diseases, offering hope for many who have exhausted other treatment options.

Stem cells promote the body’s innate ability to repair damaged tissues, offering a more organic approach to healing.

Stem cell therapy can potentially rejuvenate dachicken road gamemaged skin, reduce signs of aging, and improve overall vitality.

Unlike surgical procedures, stem cell plinko avisleonbettreatments are less invasive, leading to shorter recovery times and reduced risks.

In autism functional recovery of the brain is the primary goal of treatment.

Some of the benefits of this therapy include:

• Improved eye contact.

• Improvements in language.

• Reduction in stereotypes.

• Improvements in sleep quality and quantity.

• Increased concentration and focus.

• Improved mood.

• Longer attention span.

• Greater sociability and motivation.

• Greater motivation.

• Improved clarity of thought.

• Improvements in learning.

• Improvements in reaction time.

• Increased awareness of the surrounding world.

• Skills.

Osteoarthritis (OA) is chronic degenerative joint disease that results in clinical symptoms and structural changes in the affected joints. It primarily affects the articular cartilage, resulting in pain, swelling and stiffness. OA is a major cause of disability and pain, and its prevalence is expected to increase with the aging population and increasing obesity rates. In recent years, significant progress has been made in understanding the underlying mechanisms, diagnosis and treatment of OA, leading to potential therapeutic improvements.

Mesenchymal stem cells (MSCs) are emerging as an important area of research in cell therapy for OA. They have been extensively studied due to their immunomodulatory properties and ability to differentiate into chondrocytes, cells responsible for cartilage formation. MSCs have the potential to enhance cartilage regeneration and contribute to the restoration of functional joints.

Injuries to the attachment sites of tendons to bone, such as rotator cuff and anterior cruciate ligament injuries, are common and usually severe. The primary method of treating these types of injuries is through reconstructive surgery. The success of the reconstruction process depends on the ability of the graft to integrate into the bone. There has been considerable discussion regarding the improvement of tendon-bone integration through biological methods

Autologous mesenchymal stem cells (MSCs) are used to treat sports injuries due to their safety and no risk of rejection by the recipient's body. MSCs secrete paracrine factors that help modulate the host immune response, promote the formation of new blood vessels (angiogenesis), improve cell migration and survival, and prevent the formation of fibrous tissue. These properties make MSCs an attractive therapeutic option for a variety of sports injuries involving muscles, ligaments, tendons, bones, cartilage, and nervous tissues.

The safety and efficacy of MSC therapy in the treatment of sports injuries have been demonstrated in multiple preclinical and clinical studies. These findings provide evidence for the potential of mesenchymal stem cell (MSC)-based treatments to improve outcomes in athletes with sports injuries.

POI (premature ovarian insufficiency) is a condition characterized by early loss of ovarian function, premature menopause and associated negative effects such as: infertility, osteoporosis, neurological and hormonal disorders. The treatment is direct ovarian implantation or infusion through ovarian artery of activated MSCs. Sometimes this is combined with bioidentical hormonal implants.

Reduced ovarian reserve

A condition in which the ability to conceive is greatly reduced, both spontaneously and with known ART methods, such as in vitro fertilization. The main indirect markers of ovarian reserve are AMH (anti-Mullerian hormone) and inhibin B. After implantation of MSCs or even just growth factors, a 4 to 6-fold increase in AMH is achieved and, accordingly, the ability of the ovaries to produce a fertilized egg increases.

After the application of activated cells from the stromal-vascular fraction paravertebrally and in the discs in places with protrusions and hernias, normal mobility is restored, pain disappears and patients stop using painkillers. The need for surgical intervention disappears. The attached video is a confirmation of the effect of such therapy

Dr. Dukanov